Webinars

October 30, 2024

In this webinar, they will discuss the development and validation of a sensitive, reproducible, and robust client-specific AAV qPCR assay intended for use in viral shedding studies.

August 8, 2024

Our experts guide you through the general timelines and critical steps for taking a biotherapeutic project from initial lab engagement to final data reporting to help you avoid potential roadblocks.

June 26, 2024

Ruqi Wang's presentation will review the complexities involved in evaluating immunogenicity for cell and gene therapies. It will also provide valuable insights into the use of flow cytometry in ADA and NAb assays to assess humoral immune response.

May 23, 2024

Check out an On-Demand Spotlight interview with R&D Director of Oncology Diagnostics Karina Eterovic, MSc, PhD, NYS CoQ, as she delves deeper into recent research that reveals the intricate relationship between clonal hematopoiesis and cancer genetics.

Check out our recent on-demand webinar on Next-Generation Sequencing (NGS) for vaccine and anti-viral drug development. Kirthi Kumar Kutumbaka, Ph.D. addresses the inherent challenges associated with analyzing low viral load clinical samples and offers strategies to enhance sensitivity and specificity in NGS-based assays. 

February 27, 2024

Considering utilizing nanoString technology to develop your next RNA project? Check out our on-demand webinar to learn more about the advantages of this technology, including enzyme-free digital gene expression analysis, a dual probe hybridization process, and digital analysis to provide accurate and quantitative measurement of RNA levels.

November 1, 2023

This discussion introduces nanoString technology for digital gene expression analysis, emphasizing its enzyme-free process, dual probe hybridization, and advantages over qPCR and RNAseq. It also addresses the challenges of adopting this technology in our lab and how we are overcoming them to enhance clinical testing and biopharmaceutical research.

In this presentation, Manisha R. Diaz, Ph.D., Associate Director of Research & Development, Eurofins Viracor Biopharma, and Deepak Tomar, Ph.D., Senior Scientific Lab Lead, Eurofins Bioanalytical Services, review the advantages and disadvantages of dPCR, qPCR, and RT-qPCR as it relates to vaccine and biotherapeutic research. 

December 8, 2022 11 am EST

The webinar will explore the advantages of qPCR in advancing life-enhancing therapeutics and why patients deserve the effort to harmonize.  Validation performance characteristics are explored with a special focus on precision and sensitivity.  

November 11, 2022

This presentation covers the importance of detecting and controlling novel variants in antiviral therapy and vaccine development. It reviews NGS procedures and data submissions for assessing resistance in antiviral drug development, and discusses FDA guidelines for submitting NGS data to the Division of Antiviral Products.